130 related articles for article (PubMed ID: 6428812)
1. Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
Chandrasekar PH; Schell RF; LeFrock JL; Rolston KV; Francisco M
Chemotherapy; 1984; 30(3):165-9. PubMed ID: 6428812
[TBL] [Abstract][Full Text] [Related]
2. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
3. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F
Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273
[TBL] [Abstract][Full Text] [Related]
4. Synergy with cefsulodin or piperacillin and three aminoglycosides or aztreonam against aminoglycoside resistant strains of Pseudomonas aeruginosa.
Baltch AL; Bassey C; Hammer MC; Smith RP; Conroy JV; Michelsen PB
J Antimicrob Chemother; 1991 Jun; 27(6):801-8. PubMed ID: 1938686
[TBL] [Abstract][Full Text] [Related]
5. In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
Pfaller M; Bale M; Preston T; Howard W; Koontz F
Diagn Microbiol Infect Dis; 1986 May; 5(1):17-23. PubMed ID: 3086026
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa.
Sofianou DC; Douboyas JP
J Chemother; 1991 Feb; 3(1):3-5. PubMed ID: 1902252
[TBL] [Abstract][Full Text] [Related]
7. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital].
Ronco E; Vacheron F; Orabona A
Pathol Biol (Paris); 1987 May; 35(5):558-62. PubMed ID: 3112708
[TBL] [Abstract][Full Text] [Related]
8. Bacteriological studies with cefsulodin (CGP 7174/E), the first antipseudomonal cephalosporin.
Ullmann U
J Antimicrob Chemother; 1979 Sep; 5(5):563-7. PubMed ID: 115832
[TBL] [Abstract][Full Text] [Related]
9. Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
Watanakunakorn C
J Antimicrob Chemother; 1986 Jan; 17(1):91-5. PubMed ID: 3081474
[TBL] [Abstract][Full Text] [Related]
10. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.
Marks MI; Hammerberg S; Greenstone G; Silver B
Antimicrob Agents Chemother; 1976 Sep; 10(3):399-401. PubMed ID: 825026
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Pseudomonas aeruginosa strains isolated from hospitalized children.
Patzer J; Walkiewicz R; Dzierzanowska D
J Antimicrob Chemother; 1986 Jul; 18(1):45-9. PubMed ID: 3093444
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of tobramycin and gentamicin against Enterobacteriaceae and gentamicin-resistant, carbenicillin-resistant Pseudomonas aeruginosa.
Watanakunakorn C; Bannister T
Curr Ther Res Clin Exp; 1975 May; 17(5):488-96. PubMed ID: 805033
[No Abstract] [Full Text] [Related]
13. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
Dulong de Rosnay HL; Grimont PA; Dessaut B; Lesgouarres MT
J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.
Anderson EL; Gramling PK; Vestal PR; Farrar WE
Antimicrob Agents Chemother; 1975 Sep; 8(3):300-4. PubMed ID: 810083
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of gentamicin-resistant Pseudomonas aeruginosa.
Yu PK; Washington JA
Mayo Clin Proc; 1977 Dec; 52(12):802-5. PubMed ID: 413013
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients.
Chandrasekar PH; Crane LR; Bailey EJ
J Antimicrob Chemother; 1987 Mar; 19(3):321-9. PubMed ID: 3106305
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of cefpirome compared with that of other agents.
Raizes EG; Cantey JR
J Antimicrob Chemother; 1988 Feb; 21(2):177-81. PubMed ID: 3129388
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activity of aminoglycoside-beta-lactam combinations against Pseudomonas aeruginosa with an unusual aminoglycoside antibiogram.
Clark RB; Pakiz CB; Hostetter MK
Med Microbiol Immunol; 1990; 179(2):77-86. PubMed ID: 2113159
[TBL] [Abstract][Full Text] [Related]
19. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
Stratton CW; Weeks LS; Tausk F
J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276
[TBL] [Abstract][Full Text] [Related]
20. Resistant strains of Pseudomonas aeruginosa isolated after exposure to several beta-lactam antibiotics.
Hoekstra JL; de Neeling AJ; van Klingeren V; Stobberingh EE; van Boven CP
Eur J Clin Microbiol; 1987 Feb; 6(1):22-7. PubMed ID: 3106033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
